BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11050421)

  • 1. The biology and analysis of single disseminated tumour cells.
    Klein CA
    Trends Cell Biol; 2000 Nov; 10(11):489-93. PubMed ID: 11050421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
    Diel IJ; Solomayer EF; Bastert G
    Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micrometastases: marker of metastatic potential or evidence of residual disease?
    O'Sullivan GC; Collins JK; Kelly J; Morgan J; Madden M; Shanahan F
    Gut; 1997 Apr; 40(4):512-5. PubMed ID: 9176080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
    Allgayer H; Aguirre-Ghiso JA
    APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer.
    Heiss MM; Allgayer H; Gruetzner KU; Funke I; Babic R; Jauch KW; Schildberg FW
    Nat Med; 1995 Oct; 1(10):1035-9. PubMed ID: 7489359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.
    Klein CA; Blankenstein TJ; Schmidt-Kittler O; Petronio M; Polzer B; Stoecklein NH; Riethmüller G
    Lancet; 2002 Aug; 360(9334):683-9. PubMed ID: 12241875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
    Wollenberg B; Walz A; Kolbow K; Pauli C; Chaubal S; Andratschke M
    Onkologie; 2004 Aug; 27(4):358-62. PubMed ID: 15347890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From single disseminated tumor cells to metastasis insights from molecular genetic analyses of single cells].
    Klein CA
    Verh Dtsch Ges Pathol; 2003; 87():158-64. PubMed ID: 16888908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and molecular characterisation of disseminated tumour cells: implications for anti-cancer therapy.
    Pantel K; Woelfle U
    Biochim Biophys Acta; 2005 Sep; 1756(1):53-64. PubMed ID: 16099109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping.
    Pantel K; Otte M
    Recent Results Cancer Res; 2001; 158():14-24. PubMed ID: 11092029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
    Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
    Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer micrometastasis and tumour dormancy.
    Wikman H; Vessella R; Pantel K
    APMIS; 2008; 116(7-8):754-70. PubMed ID: 18834417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer.
    Pantel K; Aignherr C; Köllermann J; Caprano J; Riethmüller G; Köllermann MW
    Eur J Cancer; 1995 Sep; 31A(10):1627-32. PubMed ID: 7488413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous changes in tumour cell dissemination to bone marrow in colorectal cancer.
    Buxhofer-Ausch V; Ausch C; Kitzweger E; Mollik M; Reiner-Concin A; Ogris E; Stampfl M; Hamilton G; Schiessel R; Hinterberger W
    Colorectal Dis; 2010 Aug; 12(8):776-82. PubMed ID: 19456841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
    Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
    J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.